Lumbar disc degeneration (LDD) is a common cause of back pain, which is a major public health problem in Western countries. It is a common cause of work absenteeism, and its prevalence is increasing. LDD is known to be influenced by genetic factors, with estimated heritability of \>70%. Little is known, however, of the genetic processes underlying the development of disc degeneration. A number of genetic loci have been investigated through a candidate gene approach. Many early reports of candidate gene associations in LDD, however, have not been replicated ([@b1]). LDD has much in common with osteoarthritis (OA) of the knee. The pathologic changes are similar in cartilage and disc and, furthermore, rapid progression of OA of the knee is predicted by LDD ([@b2]).

The gene GDF5 is known to be involved in digit growth and certain monogenic disorders of skeletal development, and it was recently identified as playing a role in height ([@b3]). There is good evidence that variants in or near the GDF5 gene predispose to knee OA ([@b4; @b5; @b6; @b7]) and are associated with hip geometry and fracture risk ([@b8]). In addition, the gene promotes growth and repair in animal intervertebral disc tissue in vitro ([@b9]). The GDF5 gene, therefore, is a good candidate for influencing human intervertebral disc degeneration. The variant rs143383 is found in the 5′-untranslated region of the GDF5 gene on chromosome 20 at position 104 and represents a change of base from T to C. This is the most widely studied single-nucleotide polymorphism (SNP) for GDF5 and, because funding restricted our study to a single SNP, we selected this one to study for association with LDD.

PATIENTS AND METHODS
====================

Subjects
--------

We investigated the association between rs143383 and LDD in 5 independent population cohorts from Northern Europe (the Chingford study \[[@b10]\], the Hertfordshire study \[[@b11]\], Rotterdam cohorts 1 and 3 \[[@b12]\], and the TwinsUK registry \[[@b13]\]). All participants provided written consent, and local ethics committee approval had been obtained. Since the pathologic processes, including underlying genes, may differ, disc space narrowing and anterior osteophyte formation were considered separately as well as together.

Plain radiography of spine
--------------------------

Female participants in the Chingford study (n = 758) underwent plain radiography of the lateral lumbar spine, with LDD scored using a 4-point scale for disc space narrowing and anterior osteophytes over the 4 uppermost lumbar vertebrae. (L5--S1 was not reliably visualized on plain film.) Subjects were classified as having disc space narrowing (narrowing present at ≥2 levels), osteophytes (osteophytes present at ≥2 levels), or a combination (cases of narrowing plus osteophyte formation). Subjects in the Hertfordshire study (n = 336) (<http://www.mrc.soton.ac.uk/herts/>) underwent radiography and coding of degenerative change as previously described ([@b11]). Two different cohorts from the Rotterdam study (Rotterdam cohort 1 \[n = 2,577\] and Rotterdam cohort 3 \[n = 975\]) were included. These subjects underwent similar plain radiography and scoring of LDD as previously described ([@b14]). Subjects were considered to have LDD if, considering the uppermost 4 lumbar discs, either narrowing was present at ≥2 levels, osteophytes were present at ≥2 levels, or there was a combination of narrowing and osteophytes.

Magnetic resonance imaging (MRI) of the spine
---------------------------------------------

Female twins (n = 613) from the TwinsUK cohort who had previously undergone T2-weighted sagittal MRI of the lumbar spine were selected. The scans had been coded for degenerative change using a 4-point scale (0--3) for the following features: disc height, disc signal intensity, disc bulge, and anterior osteophyte. The individual traits were investigated, and subjects were considered to be cases if they had a score for a particular trait of ≥2 at 2 or more levels (L1/2 to L5--S1).

Genotyping
----------

For the Rotterdam cohort, data on genotypes at rs143383 were obtained from the results of a genome-wide association scan using the version 3 Illumina Infinium II HumanHap550 SNP chip array. Genotyping procedures were followed according to the recommendations of the manufacturer (Illumina), as previously described ([@b15]). For the Chingford, Hertfordshire, and TwinsUK cohorts, genomic DNA was extracted from peripheral blood leukocytes from affected individuals and controls using standard protocols. Genotyping was carried out by Kbioscience Ltd (Hertfordshire, UK). The rs143383 SNP was genotyped using KASPar chemistry, which is a competitive allele-specific polymerase chain reaction SNP genotyping system using fluorescence resonance energy transfer quencher cassette oligos. Genotyping accuracy, as determined from the genotype concordance between duplicate samples, was 100% (52 samples genotyped in duplicate as a control). The polymorphism was in Hardy-Weinberg equilibrium in controls (*P* \> 0.05).

Statistical analysis
--------------------

To study the relationship between rs143383 and LDD, a logistic regression model was applied. All analyses were performed with and without adjustment for sex, age, and body mass index (BMI) in each study separately. Meta-analysis of the results in the different cohorts was carried out in the statistical environment R, and forest plots were produced. Heterogeneity was evaluated with the Q statistic and I^2^. If heterogeneity existed (I^2^ \>25%), a random-effects model was used for the analysis; otherwise, a fixed-effects model (inverse variance method) was applied. Since many reported associations of genetic variants are not yet replicated, we wished to determine the likelihood of our finding being a true positive, so the false-positive report probability was calculated ([@b16]).

RESULTS
=======

Characteristics of the 5 population samples are shown in [Table 1](#tbl1){ref-type="table"}. The total sample size was 5,259. The Chingford cohort consisted entirely of women, and in the TwinsUK group women formed the vast majority. Sex distribution was more equable in the Hertfordshire and Rotterdam studies. With regard to the 2 phenotypes considered, the number of cases was broadly similar for disc space narrowing (range 9--19%) but varied greatly for prevalence of osteophytes (range 6--62%). Both age and BMI (where available) were found to be positively associated in those cohorts having a broad age range, so were adjusted for in the analyses.

###### 

Characteristics of the 5 study groups included in the meta-analysis[\*](#tf1-1){ref-type="table-fn"}

                                          Rotterdam cohort 1   Rotterdam cohort 3   Chingford study     TwinsUK registry   Hertfordshire birth cohort
  --------------------------------------- -------------------- -------------------- ------------------- ------------------ ----------------------------
  Imaging method                          Plain radiography    Plain radiography    Plain radiography   T2-weighted MRI    Plain radiography
  Sample size                             2,577                975                  758                 613                336
  \% women                                57                   58                   100                 97                 39
  Age, mean (range) years                 65.7 (55--90)        54.7 (48--60)        62.9 (53--77)       53.6 (19--73)      65.8 (61--73)
  BMI, mean (range) kg/m^2^               26.3 (16--45)        27.1 (14--57)        26.6 (17--47)       25.0 (16--51)      26.9 (16--40)
  Disc space narrowing                    490 (19)             102 (10)             68 (9)              108 (17)           50 (15)
  Osteophytes                             781 (30)             179 (18)             175 (23)            35 (6)             208 (62)
  Disc space narrowing plus osteophytes   305 (12)             60 (6)               54 (7)              19 (3)             40 (12)
  MAF                                     39.9                 40.4                 38.6                34.9               32.3

Except where indicated otherwise, values are the number (%). MRI = magnetic resonance imaging; BMI = body mass index; MAF = minor allele frequency.

Minor allele frequencies of rs143383 were broadly similar across the study groups and consistent with that reported in HapMap (C allele 33.3%). [Table 2](#tbl2){ref-type="table"} shows the number of cases and controls with the different alleles of rs143383. The results of the meta-analysis for the association between the T allele and the LDD phenotypes in women, adjusted for age and BMI, are shown in [Figure 1](#fig01){ref-type="fig"}. (Results for the total sample are shown in Supplementary Figure 1, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131>.) A significant association was found with the combination of disc space narrowing plus osteophytes in women, with an odds ratio (OR) of 1.72 (95% confidence interval \[95% CI\] 1.15--2.57) (*P* = 0.008). Heterogeneity was not detected, so a fixed-effects model was used.

![Forest plots of the fixed-effects meta-analysis of the odds ratios (ORs) and 95% confidence intervals (95% CIs) for A, disc space narrowing, B, osteophytes, and C, both disc space narrowing and osteophytes in women in the Rotterdam study 1 (RS1), Rotterdam study 3, Chingford, and TwinsUK cohorts, adjusted for age and body mass index (BMI); in the Hertfordshire cohort, adjusted for age; and in all studies combined, adjusted for age and BMI. Squares represent the ORs for the T allele; bars show the 95% CIs. Diamonds represent the pooled ORs and 95% CIs. The pooled OR for disc space narrowing and osteophytes combined was 1.72 (95% CI 1.15--2.57) (*P* = 0.008).](art0063-0708-f1){#fig01}

###### 

Genotype distribution for rs143383 in women, by trait and cohort[\*](#tf2-1){ref-type="table-fn"}

                                         Cases   Controls                          
  -------------------------------------- ------- ---------- ---- ----- ----- ----- -------
  Disc space narrowing                                                             
   Rotterdam cohort 1                    114     173        49   420   517   190   1,463
   Rotterdam cohort 3                    30      22         9    178   244   89    572
   Chingford                             29      28         11   269   307   114   758
   TwinsUK                               43      44         17   210   217   58    589
   Hertfordshire                         7       9          1    56    41    16    130
  Osteophytes                                                                      
   Rotterdam cohort 1                    150     177        50   384   512   189   1,462
   Rotterdam cohort 3                    33      43         20   175   223   78    572
   Chingford                             69      80         26   229   255   99    758
   TwinsUK                               17      13         3    236   249   71    589
   Hertfordshire                         35      30         12   28    20    5     130
  Disc space narrowing and osteophytes                                             
   Rotterdam cohort 1                    70      103        21   464   586   218   1,462
   Rotterdam cohort 3                    15      14         4    193   252   94    572
   Chingford                             25      23         6    273   312   119   758
   TwinsUK                               9       7          2    246   256   72    592
   Hertfordshire                         5       8          1    58    42    16    130

Values are the number of subjects with each genotype.

Distributions of the rs143383 genotypes and ORs unadjusted and adjusted for age are shown for women in each of the cohorts in Supplementary Table 1, available on the *Arthritis & Rheumatism* web site at <http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131>. Using a relatively high prior probability of 20%, the false-positive report probability was calculated, assuming expected effect sizes of OR 1.2 and OR 1.5, for the predisposing T allele. The false-positive report probability is the probability of no true association between a genetic variant and disease given a statistically significant finding, which depends not only on the observed *P* value but also on both the prior probability that the association is real and the statistical power of the test. The false-positive report probability for adjusted values was 36% and 12%, respectively, suggesting that this is not likely to be a false-positive finding.

DISCUSSION
==========

An association between the GDF5 SNP rs143383 and LDD in women is an important finding and is consistent with the known association of the T allele with OA ([@b17]). LDD is common and known to be a cause of low back pain, a condition that results in great social costs. It has been established that LDD is highly heritable, and some genetic variants have been identified (for review, see ref.[@b1]), but much of the variation remains to be accounted for. The finding of an association with the combination of disc space narrowing and osteophytes, but only in women, may reflect the sample size or may indicate that the effect is detectable only in the most severely affected. Sex-specificity of the effects of genetic variants is well recognized in OA.

GDF5 is a proven variant in peripheral joint OA; this has been demonstrated in a number of populations. Furthermore, it is associated with skeletal height, suggesting mediation by either disc or vertebral body height or long bone length ([@b8]). GDF5 was selected as an OA candidate gene initially because phalangoepiphyseal dysplasia patients develop severe, early-onset hip OA. Miyamoto et al ([@b5]) performed a case--control association study of a number of SNPs around GDF5 and found the most significant to be rs143383. This association has been shown for both hip and knee OA in both Japanese and Han Chinese populations and, more recently, confirmed in European populations in 2 published meta-analyses ([@b6], [@b17]). Since the T to C mutation at position +104 lies in the promoter region of GDF5, the hypothesis is that the variant influences GDF5 transcription, with individuals with OA having reduced transcriptional ability.

This study has a number of strengths and weaknesses. First, it combines a number of well-characterized cohorts that have been subjected to LDD phenotyping, albeit using different methods. The study of degenerative disease of the disc lags behind the study of hip, knee, and hand OA. In addition, LDD suffers from a lack of standardized epidemiologic definitions, which hampers attempts to study it in a systematic way. The use of twins and any relatedness within the other cohorts was taken into account. This study had 80% power to detect an OR for the T allele of 1.19 or higher for narrowing and 1.15 for osteophytes in the total sample size with *P* \< 0.05 (assuming an additive genetic model and T allele frequency of 60%, using Quanto software version 1.2.4). This is further supported by the results of the false-positive report probability, suggesting that the results are more likely to be true positive than false positive.

We investigated whether the 5′-untranslated region SNP rs143383 GDF5 polymorphism was associated with LDD using 5 cohorts of European descent and found evidence of association in women. This SNP is thought to result in reduced transcription of GDF5, a prochondrogenic growth factor which has been shown to increase fiber size in the ligament complex model of knee instability in rats. One might postulate a number of mechanisms by which the SNP exerts its influence on LDD risk, including direct effects on the disc itself or by influence on periarticular structures such as the longitudinal spinal ligaments. Further work is needed to establish its mechanism of action, and this may reveal cellular pathways leading to a greater understanding of the pathophysiology of lumbar disc degeneration.
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